During the past decade, Rancho Research Institute conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 6 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 6 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rancho Research Institute" #1 sponsor was "Flint Rehabilitation Devices, LLC" with 3 trials, followed by "Supernus Pharmaceuticals, Inc." with 2 trials sponsored, "AnGes USA, Inc." with 1 trials sponsored, "Aquestive Therapeutics" with 1 trials sponsored and "Engage Therapeutics, Inc." with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rancho Research Institute" #1 collaborator was "Rancho Research Institute, Inc." with 3 trials as a collaborator, "Solstice Neurosciences" with 2 trials as a collaborator, "Bill and Melinda Gates Foundation" with 1 trials as a collaborator, "Columbia University" with 1 trials as a collaborator and "Covance" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Rancho Research Institute" are "Cerebral Stroke" (2 trials), "Epilepsy" (2 trials), "Multiple Sclerosis" (2 trials), "Spasticity" (2 trials) and "ADPKD" (1 trials). Many other conditions were trialed in "Rancho Research Institute" in a lesser frequency.

Most popular intervention types in "Rancho Research Institute" are "Drug" (7 trials), "Device" (6 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Phase 2; High Dose MYOBLOC" (2 trials), "Phase 2; Low Dose MYOBLOC" (2 trials), "Phase 2; Placebo" (2 trials), "Phase 3; MYOBLOC" (2 trials) and "Phase 3; Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Rancho Research Institute" are 13 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Rancho Research Institute". 1 are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Rancho Research Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Rancho Research Institute, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".